Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 4798639, 22 pages
http://dx.doi.org/10.1155/2016/4798639
Review Article

Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence

1Excellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), Florence, Italy
2Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy
3Nephrology Unit, Meyer Children’s University Hospital, Florence, Italy

Received 11 February 2016; Revised 15 July 2016; Accepted 18 August 2016

Academic Editor: Franca Fagioli

Copyright © 2016 Anna Julie Peired et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Friedenstein, I. I. Piatetzky-Shapiro, and K. V. Petrakova, “Osteogenesis in transplants of bone marrow cells,” Journal of Embryology and Experimental Morphology, vol. 16, no. 3, pp. 381–390, 1966. View at Google Scholar · View at Scopus
  2. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Le Blanc and D. Mougiakakos, “Multipotent mesenchymal stromal cells and the innate immune system,” Nature Reviews Immunology, vol. 12, no. 5, pp. 383–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Morigi and A. Benigni, “Mesenchymal stem cells and kidney repair,” Nephrology Dialysis Transplantation, vol. 28, no. 4, pp. 788–793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kassem, L. Mosekilde, and E. F. Eriksen, “1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells,” Journal of Bone and Mineral Research, vol. 8, no. 12, pp. 1453–1458, 1993. View at Google Scholar · View at Scopus
  6. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-T. Zhang, Z.-L. Liu, X.-Q. Yao, Z.-J. Yang, and R.-X. Xu, “Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study,” Cytotherapy, vol. 14, no. 10, pp. 1203–1214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Bianco, X. Cao, P. S. Frenette et al., “The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine,” Nature Medicine, vol. 19, no. 1, pp. 35–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Bourin, B. A. Bunnell, L. Casteilla et al., “Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT),” Cytotherapy, vol. 15, no. 6, pp. 641–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Grisendi, C. Annerén, L. Cafarelli et al., “GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion,” Cytotherapy, vol. 12, no. 4, pp. 466–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Krampera, J. Galipeau, Y. Shi, K. Tarte, and L. Sensebe, “Immunological characterization of multipotent mesenchymal stromal cells—the International Society for Cellular Therapy (ISCT) working proposal,” Cytotherapy, vol. 15, no. 9, pp. 1054–1061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Galderisi, A. Calarco, M. A. B. Melone, and G. Peluso, “Is it possible to improve the success rate of cellular therapy based on mesenchymal stem cells?” Journal of Stem Cells Research, Reviews & Reports, vol. 1, pp. 1017–1019, 2014. View at Google Scholar
  15. J. Campisi and F. D'Adda Di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Squillaro, G. Peluso, and U. Galderisi, “Clinical trials with mesenchymal stem cells: an update,” Cell Transplantation, vol. 25, no. 5, pp. 829–848, 2016. View at Publisher · View at Google Scholar
  18. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Gronthos, M. Mankani, J. Brahim, P. G. Robey, and S. Shi, “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13625–13630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. La Noce, F. Paino, A. Spina et al., “Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy,” Journal of Dentistry, vol. 42, no. 7, pp. 761–768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Kermani, F. Fathi, and S. J. Mowla, “Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy,” Rejuvenation Research, vol. 11, no. 2, pp. 379–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Gronthos and A. C. W. Zannettino, “Methods for the purification and characterization of human adipose-derived stem cells,” Methods in Molecular Biology, vol. 702, pp. 109–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Orbay, M. Tobita, and H. Mizuno, “Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications,” Stem Cells International, vol. 2012, Article ID 461718, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. In 't Anker, S. A. Scherjon, C. Kleijburg-van der Keur et al., “Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation,” Blood, vol. 102, no. 4, pp. 1548–1549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-S. Tsai, J.-L. Lee, Y.-J. Chang, and S.-M. Hwang, “Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol,” Human Reproduction, vol. 19, no. 6, pp. 1450–1456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bruno, B. Bussolati, C. Grange et al., “Isolation and characterization of resident mesenchymal stem cells in human glomeruli,” Stem Cells and Development, vol. 18, no. 6, pp. 867–880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Li, U. Ariunbold, N. Suhaimi et al., “Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity,” Journal of the American Society of Nephrology, vol. 26, no. 1, pp. 81–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Pelekanos, J. Li, M. Gongora et al., “Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities,” Stem Cell Research, vol. 8, no. 1, pp. 58–73, 2012. View at Publisher · View at Google Scholar
  30. M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. G. Edwards and P. Hollands, “Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation?” Reproductive BioMedicine Online, vol. 14, no. 3, pp. 396–401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Flynn, F. Barry, and T. O'Brien, “UC blood-derived mesenchymal stromal cells: an overview,” Cytotherapy, vol. 9, no. 8, pp. 717–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Wang, J. Li, Y. Zhang et al., “Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study,” Arthritis Research & Therapy, vol. 16, no. 2, article R79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Tang, H. Xie, J. Chen et al., “Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling,” Stem Cells and Development, vol. 22, no. 4, pp. 668–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Li, L. Liu, D. Meng et al., “Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus,” Stem Cells and Development, vol. 21, no. 13, pp. 2387–2394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M.-C. Kastrinaki, P. Sidiropoulos, S. Roche et al., “Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 741–749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Guiducci, M. Manetti, E. Romano et al., “Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro,” Annals of the Rheumatic Diseases, vol. 70, no. 11, pp. 2011–2021, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Subramanian, G. Shu-Uin, N. Kae-Siang et al., “Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1886–1895, 2012. View at Publisher · View at Google Scholar
  39. T. A. Moseley, M. Zhu, and M. H. Hedrick, “Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery,” Plastic and Reconstructive Surgery, vol. 118, no. 3, pp. 121S–128S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Bortolotti, L. Ukovich, V. Razban et al., “In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure,” Stem Cell Reports, vol. 4, no. 3, pp. 332–339, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Ezquer, M. Giraud-Billoud, D. Carpio, F. Cabezas, P. Conget, and M. Ezquer, “Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus,” BioMed Research International, vol. 2015, Article ID 164703, 23 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Rahman, F. Shad, and M. C. Smith, “Acute kidney injury: a guide to diagnosis and management,” American Family Physician, vol. 86, no. 7, pp. 631–639, 2012. View at Google Scholar · View at Scopus
  43. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., “Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638–14643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. K. Crow, “Developments in the clinical understanding of lupus,” Arthritis Research & Therapy, vol. 11, no. 5, article 245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. F. A. Houssiau and E. M. Ginzler, “Current treatment of lupus nephritis,” Lupus, vol. 17, no. 5, pp. 426–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Munir and H. M. McGettrick, “Mesenchymal stem cell therapy for autoimmune disease: risks and rewards,” Stem Cells and Development, vol. 24, no. 18, pp. 2091–2100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Sun, K. Akiyama, H. Zhang et al., “Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans,” Stem Cells, vol. 27, no. 6, pp. 1421–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Pileggi, X. Xu, J. Tan, and C. Ricordi, “Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials,” Current Opinion in Organ Transplantation, vol. 18, no. 6, pp. 672–681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. K. E. Lamb, S. Lodhi, and H.-U. Meier-Kriesche, “Long-term renal allograft survival in the United States: a critical reappraisal,” American Journal of Transplantation, vol. 11, no. 3, pp. 450–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. E. J. Reinders, T. J. Rabelink, and J. W. de Fijter, “The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation,” Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 44–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Sun, D. Wang, J. Liang et al., “Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 62, no. 8, pp. 2467–2475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Tan, W. Wu, X. Xu et al., “Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial,” The Journal of the American Medical Association, vol. 307, no. 11, pp. 1169–1177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Perico, F. Casiraghi, E. Gotti et al., “Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation,” Transplant International, vol. 26, no. 9, pp. 867–878, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Mahmood, D. Lu, M. Lu, and M. Chopp, “Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells,” Neurosurgery, vol. 53, no. 3, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Monsel, Y.-G. Zhu, S. Gennai, Q. Hao, J. Liu, and J. W. Lee, “Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells,” Anesthesiology, vol. 121, no. 5, pp. 1099–1121, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Wei, X. Yang, Z.-P. Han, F.-F. Qu, L. Shao, and Y.-F. Shi, “Mesenchymal stem cells: a new trend for cell therapy,” Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 747–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Göransson, C. Johnsson, A. Jacobson, P. Heldin, R. Hällgren, and P. Hansell, “Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat,” Nephrology Dialysis Transplantation, vol. 19, no. 4, pp. 823–830, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. M. B. Herrera, B. Bussolati, S. Bruno et al., “Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury,” Kidney International, vol. 72, no. 4, pp. 430–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. S.-C. Hung, R. R. Pochampally, S.-C. Hsu et al., “Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo,” PLoS ONE, vol. 2, article e416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Liu, J. Tian, J. Cheng, and J. Zhang, “Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney,” Journal of Cellular Biochemistry, vol. 114, no. 12, pp. 2677–2689, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth, “MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines,” Blood, vol. 109, no. 9, pp. 4055–4063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Si, X. Liu, J. Li, and X. Wu, “Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury,” International Journal of Clinical and Experimental Pathology, vol. 8, pp. 12368–12378, 2015. View at Google Scholar
  64. X.-Y. Si, J.-J. Li, T. Yao, and X.-Y. Wu, “Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4,” Molecular Medicine Reports, vol. 9, no. 5, pp. 1794–1798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Sohni and C. M. Verfaillie, “Mesenchymal stem cells migration homing and tracking,” Stem Cells International, vol. 2013, Article ID 130763, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Tögel, J. Isaac, Z. Hu, K. Weiss, and C. Westenfelder, “Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury,” Kidney International, vol. 67, no. 5, pp. 1772–1784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Wang, Q. Zhang, Z. Zhuo et al., “Enhanced homing of CXCR-4 modified bone marrow-derived mesenchymal stem cells to acute kidney injury tissues by micro-bubble-mediated ultrasound exposure,” Ultrasound in Medicine and Biology, vol. 42, no. 2, pp. 539–548, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, “Paracrine mechanisms in adult stem cell signaling and therapy,” Circulation Research, vol. 103, no. 11, pp. 1204–1219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, “Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms,” American Journal of Physiology—Renal Physiology, vol. 289, no. 1, pp. F31–F42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. J. S. Duffield and J. V. Bonventre, “Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury,” Kidney International, vol. 68, no. 5, pp. 1956–1961, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. J. S. Duffield, K. M. Park, L.-L. Hsiao et al., “Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells,” The Journal of Clinical Investigation, vol. 115, no. 7, pp. 1743–1755, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. H. Jiang, G. Li, J. Liu et al., “Nestin+ kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury,” Biomaterials, vol. 50, no. 1, pp. 56–66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. K. W. Liechty, T. C. Mackenzie, A. F. Shaaban et al., “Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep,” Nature Medicine, vol. 6, no. 11, pp. 1282–1286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Casiraghi, G. Remuzzi, and N. Perico, “Mesenchymal stromal cells to promote kidney transplantation tolerance,” Current Opinion in Organ Transplantation, vol. 19, no. 1, pp. 47–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Casiraghi, N. Perico, M. Cortinovis, and G. Remuzzi, “Mesenchymal stromal cells in renal transplantation: opportunities and challenges,” Nature Reviews Nephrology, vol. 12, no. 4, pp. 241–253, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén, “HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells,” Experimental Hematology, vol. 31, no. 10, pp. 890–896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. J. M. Ryan, F. P. Barry, J. M. Murphy, and B. P. Mahon, “Mesenchymal stem cells avoid allogeneic rejection,” Journal of Inflammation, vol. 2, article 8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Chen, E. E. Tredget, P. Y. G. Wu, and Y. Wu, “Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing,” PLoS ONE, vol. 3, no. 4, Article ID e1886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M.-H. Chien, M.-Y. Bien, C.-C. Ku et al., “Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury,” Critical Care Medicine, vol. 40, no. 4, pp. 1245–1253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Ionescu, R. N. Byrne, T. van Haaften et al., “Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 303, no. 11, pp. L967–L977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Jang, M. Jeong, S. Kim et al., “Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupus model by suppressing follicular helper T-cell development,” Cell Transplantation, vol. 25, no. 1, pp. 1–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  83. X.-X. Jiang, Y. Zhang, B. Liu et al., “Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells,” Blood, vol. 105, no. 10, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. E. S. Kim, Y. S. Chang, S. J. Choi et al., “Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice,” Respiratory Research, vol. 12, article108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Krampera, S. Glennie, J. Dyson et al., “Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide,” Blood, vol. 101, no. 9, pp. 3722–3729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Le Blanc, L. Tammik, B. Sundberg, S. E. Haynesworth, and O. Ringdén, “Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex,” Scandinavian Journal of Immunology, vol. 57, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. Z.-X. Liang, J.-P. Sun, P. Wang, Q. Tian, Z. Yang, and L.-A. Chen, “Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury,” Chinese Medical Journal, vol. 124, no. 17, pp. 2715–2722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe, “Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells,” The Journal of Immunology, vol. 177, no. 4, pp. 2080–2087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Németh, A. Leelahavanichkul, P. S. T. Yuen et al., “Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production,” Nature Medicine, vol. 15, no. 1, pp. 42–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Poggi, C. Prevosto, A.-M. Massaro et al., “Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors,” Journal of Immunology, vol. 175, no. 10, pp. 6352–6360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. I. Rasmusson, O. Ringdén, B. Sundberg, and K. Le Blanc, “Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells,” Transplantation, vol. 76, no. 8, pp. 1208–1213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation,” Blood, vol. 107, no. 4, pp. 1484–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Sun, Z.-B. Han, W. Liao et al., “Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors,” Cellular Physiology and Biochemistry, vol. 27, no. 5, pp. 587–596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. Q.-Z. Zhang, W.-R. Su, S.-H. Shi et al., “Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing,” STEM CELLS, vol. 28, no. 10, pp. 1856–1868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. J. A. Zullo, E. P. Nadel, M. M. Rabadi et al., “The secretome of hydrogel-coembedded endothelial progenitor cells and mesenchymal stem cells instructs macrophage polarization in endotoxemia,” Stem Cells Translational Medicine, vol. 4, no. 7, pp. 852–861, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. U. Galderisi and A. Giordano, “The gap between the physiological and therapeutic roles of mesenchymal stem cells,” Medicinal Research Reviews, vol. 34, no. 5, pp. 1100–1126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. M. E. Bernardo and W. E. Fibbe, “Mesenchymal stromal cells: sensors and switchers of inflammation,” Cell Stem Cell, vol. 13, no. 4, pp. 392–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Chen, H. Qian, W. Zhu et al., “Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury,” Stem Cells and Development, vol. 20, no. 1, pp. 103–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Tögel, P. Zhang, Z. Hu, and C. Westenfelder, “VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 2109–2114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. B. Imberti, M. Morigi, S. Tomasoni et al., “Insulin-like growth factor-1 sustains stem cell-mediated renal repair,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2921–2928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Zhang, Y. Li, J. Chen et al., “Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells,” Brain Research, vol. 1030, no. 1, pp. 19–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. S. B. Miller, D. R. Martin, J. Kissane, and M. R. Hammerman, “Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11876–11880, 1992. View at Publisher · View at Google Scholar · View at Scopus
  103. S. B. Miller, D. R. Martin, J. Kissane, and M. R. Hammerman, “Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats,” American Journal of Physiology, vol. 266, no. 1, pp. F129–F134, 1994. View at Google Scholar · View at Scopus
  104. B. F. Schrijvers, A. Flyvbjerg, and A. S. De Vriese, “The role of vascular endothelial growth factor (VEGF) in renal pathophysiology,” Kidney International, vol. 65, no. 6, pp. 2003–2017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Zhou, H. Xu, W. Xu et al., “Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro,” Stem Cell Research and Therapy, vol. 4, article 34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Thébaud and D. J. Stewart, “Exosomes: cell garbage can, therapeutic carrier, or trojan horse?” Circulation, vol. 126, no. 22, pp. 2553–2555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Bruno, C. Grange, F. Collino et al., “Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury,” PLoS ONE, vol. 7, no. 3, Article ID e33115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. F. Collino, M. C. Deregibus, S. Bruno et al., “Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs,” PLoS ONE, vol. 5, no. 7, Article ID e11803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Bruno, C. Grange, M. C. Deregibus et al., “Mesenchymal stem cell-derived microvesicles protect against acute tubular injury,” Journal of the American Society of Nephrology, vol. 20, no. 5, pp. 1053–1067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. G.-Q. Ju, J. Cheng, L. Zhong et al., “Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction,” PLoS ONE, vol. 10, no. 3, Article ID e0121534, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. D. W. Zhang, H. Qiu, Y. M. Mei, H. Fu, and H. G. Zheng, “Repair effects of umbilical cord mesenchymal stem cells on podocyte damage of iga nephropathy,” Journal of Biological Regulators and Homeostatic Agents, vol. 29, no. 3, pp. 609–617, 2015. View at Google Scholar · View at Scopus
  112. M. G. Monteiro Carvalho Mori da Cunha, S. Zia, F. Oliveira Arcolino et al., “Amniotic fluid derived stem cells with a renal progenitor phenotype inhibit interstitial fibrosis in renal ischemia and reperfusion injury in rats,” PLoS ONE, vol. 10, no. 8, Article ID e0136145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. A. F. da Silva, K. Silva, L. A. Reis, V. P. C. Teixeira, and N. Schor, “Bone marrow-derived mesenchymal stem cells and their conditioned medium attenuate fibrosis in an irreversible model of unilateral ureteral obstruction,” Cell Transplantation, vol. 24, no. 12, pp. 2657–2666, 2015. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Mohammadzadeh, R. Halabian, A. Gharehbaghian et al., “Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity,” Cell Stress and Chaperones, vol. 17, no. 5, pp. 553–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Arslan, R. C. Lai, M. B. Smeets et al., “Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury,” Stem Cell Research, vol. 10, no. 3, pp. 301–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Bellomo, J. A. Kellum, and C. Ronco, “Acute kidney injury,” The Lancet, vol. 380, no. 9843, pp. 756–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. F. E. Tögel and C. Westenfelder, “Kidney protection and regeneration following acute injury: progress through stem cell therapy,” American Journal of Kidney Diseases, vol. 60, no. 6, pp. 1012–1022, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Gooch, J. Doty, J. Flores et al., “Initial report on a phase I clinical trial: prevention and treatment of post-operative Acute Kidney Injury with allogeneic Mesenchymal Stem Cells in patients who require on-pump cardiac surgery,” Cellular Therapy and Transplantation, vol. 1, no. 2, pp. 31–35, 2008. View at Publisher · View at Google Scholar
  119. F. Bianchi, E. Sala, C. Donadei, I. Capelli, and G. La Manna, “Potential advantages of acute kidney injury management by mesenchymal stem cells,” World Journal of Stem Cells, vol. 6, no. 5, pp. 644–650, 2014. View at Publisher · View at Google Scholar
  120. K. Brück, V. S. Stel, S. Fraser et al., “Translational research in nephrology: chronic kidney disease prevention and public health,” Clinical Kidney Journal, vol. 8, no. 6, pp. 647–655, 2015. View at Publisher · View at Google Scholar
  121. D. A. Papazova, N. R. Oosterhuis, H. Gremmels, A. van Koppen, J. A. Joles, and M. C. Verhaar, “Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis,” Disease Models and Mechanisms, vol. 8, no. 3, pp. 281–293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Gallagher and R. J. Suckling, “Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?” Diabetes, Obesity and Metabolism, vol. 18, no. 7, pp. 641–647, 2016. View at Publisher · View at Google Scholar · View at Scopus
  123. M. E. Ezquer, F. E. Ezquer, M. L. Arango-Rodríguez, and P. A. Conget, “MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy,” Biological Research, vol. 45, no. 3, pp. 289–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. L. Malaga-Dieguez, D. Bouhassira, D. Gipson, and H. Trachtman, “Novel therapies for FSGS: preclinical and clinical studies,” Advances in Chronic Kidney Disease, vol. 22, no. 2, pp. e1–e6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. H. Ma, Y. Wu, Y. Xu, L. Sun, and X. Zhang, “Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis,” American Journal of the Medical Sciences, vol. 346, no. 6, pp. 486–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Belingheri, L. Lazzari, V. Parazzi et al., “Allogeneic mesenchymal stem cell infusion for the stabilization offocal segmental glomerulosclerosis,” Biologicals, vol. 41, no. 6, pp. 439–445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Liang, H. Zhang, B. Hua et al., “Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study,” Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1423–1429, 2010. View at Publisher · View at Google Scholar
  128. D. Wang, X. Feng, L. Lu et al., “A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 66, no. 8, pp. 2234–2245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. N. Perico, F. Casiraghi, M. Introna et al., “Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 412–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. M. E. J. Reinders, J. W. de Fijter, H. Roelofs et al., “Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study,” Stem Cells Translational Medicine, vol. 2, no. 2, pp. 107–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. M. E. J. Reinders, J. R. Bank, G. J. Dreyer et al., “Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients,” Journal of Translational Medicine, vol. 12, article 331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. M. E. J. Reinders, G. J. Dreyer, J. R. Bank et al., “Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study,” Journal of Translational Medicine, vol. 13, no. 1, article 344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. C. Mudrabettu, V. Kumar, A. Rakha et al., “Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study,” Nephrology, vol. 20, no. 1, pp. 25–33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. A. V. Vanikar, H. L. Trivedi, A. Feroze, K. V. Kanodia, S. D. Dave, and P. R. Shah, “Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness,” International Urology and Nephrology, vol. 43, no. 1, pp. 225–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. A. V. Vanikar and H. L. Trivedi, “Stem cell transplantation in living donor renal transplantation for minimization of immunosuppression,” Transplantation, vol. 94, no. 8, pp. 845–850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. H. Lee, J. B. Park, S. Lee, S. Baek, H. Kim, and S. J. Kim, “Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study,” Journal of Translational Medicine, vol. 11, no. 1, article 96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. Peng, M. Ke, L. Xu et al., “Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study,” Transplantation, vol. 95, no. 1, pp. 161–168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Mastri, H. Lin, and T. Lee, “Enhancing the efficacy of mesenchymal stem cell therapy,” World Journal of Stem Cells, vol. 6, no. 2, pp. 82–93, 2014. View at Publisher · View at Google Scholar
  139. Y. S. Kim, J. S. Kwon, M. H. Hong et al., “Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin,” BMC Cell Biology, vol. 14, no. 1, article 38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. S. R. Wallace, M. M. Oken, K. L. Lunetta, A. Panoskaltsis-Mortari, and A. M. Masellis, “Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients,” Cancer, vol. 91, no. 7, pp. 1219–1230, 2001. View at Google Scholar · View at Scopus
  141. K. Kemp, R. Morse, S. Wexler et al., “Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy,” Annals of Hematology, vol. 89, no. 7, pp. 701–713, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. B. Bozkurt and M. Kiliç, “Marginal donors in renal transplantation,” Transplantation Proceedings, vol. 47, no. 5, pp. 1273–1281, 2015. View at Publisher · View at Google Scholar · View at Scopus
  143. G. Gopalakrishnan and S. P. Gourabathini, “Marginal kidney donor,” Indian Journal of Urology, vol. 23, no. 3, pp. 286–293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Morigi, C. Rota, and G. Remuzzi, “Mesenchymal stem cells in kidney repair,” in Mesenchymal Stem Cells, M. Gnecchi, Ed., vol. 1416 of Methods in Molecular Biology, pp. 89–107, 2016. View at Publisher · View at Google Scholar
  145. R. R. Sharma, K. Pollock, A. Hubel, and D. McKenna, “Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices,” Transfusion, vol. 54, no. 5, pp. 1418–1437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  146. N. D'Souza, F. Rossignoli, G. Golinelli et al., “Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies,” BMC Medicine, vol. 13, no. 1, article 186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  147. Z. Pasha, Y. Wang, R. Sheikh, D. Zhang, T. Zhao, and M. Ashraf, “Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium,” Cardiovascular Research, vol. 77, no. 1, pp. 134–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Polchert, J. Sobinsky, G. W. Douglas et al., “IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease,” European Journal of Immunology, vol. 38, no. 6, pp. 1745–1755, 2008. View at Publisher · View at Google Scholar · View at Scopus